Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Cerebrospinal fluid leak after bone marrow biopsy.

Fox TA, Jager R, Ardeshna KM.

Br J Haematol. 2017 Oct 19. doi: 10.1111/bjh.14963. [Epub ahead of print] No abstract available.

PMID:
29048111
2.

A Case of Psoriasis Vulgaris Aggravated with Atorvastatin, Aided by Concomitant Cyclosporine.

Ardeshna KP, Someshwar S, Rohatgi S, Jerajani HR.

Indian J Dermatol. 2017 Sep-Oct;62(5):537-538. doi: 10.4103/ijd.IJD_749_16. No abstract available.

3.

Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.

Gleeson M, Counsell N, Cunningham D, Chadwick N, Lawrie A, Hawkes EA, McMillan A, Ardeshna KM, Jack A, Smith P, Mouncey P, Pocock C, Radford JA, Davies J, Turner D, Kruger A, Johnson P, Gambell J, Linch D.

Ann Oncol. 2017 Oct 1;28(10):2511-2516. doi: 10.1093/annonc/mdx353.

PMID:
28961838
4.

Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.

Eyre TA, Phillips EH, Linton KM, Kassam S, Gibb A, Allibone S, Radford J, Peggs K, Burton C, Stewart G, LeDieu R, Booth C, Osborne WL, Miall F, Eyre DW, Ardeshna KM, Collins GP.

Br J Haematol. 2017 Nov;179(3):471-479. doi: 10.1111/bjh.14898. Epub 2017 Aug 31.

PMID:
28857136
5.

Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise.

Bharucha T, Rutherford A, Skeoch S, Alavi A, Brown M, Galloway J; FDG-PET/CT in fever of unknown origin working group.

Clin Radiol. 2017 Sep;72(9):764-771. doi: 10.1016/j.crad.2017.04.014. Epub 2017 Jun 7. Review.

PMID:
28600002
6.

Haemophagocytic lymphohistiocytosis as a consequence of untreated B-cell chronic lymphocytic leukaemia.

Bailey C, Dearden C, Ardeshna K.

BMJ Case Rep. 2017 Apr 26;2017. pii: bcr-2016-219057. doi: 10.1136/bcr-2016-219057.

PMID:
28446487
7.

Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial.

Kühnl A, Cunningham D, Counsell N, Hawkes EA, Qian W, Smith P, Chadwick N, Lawrie A, Mouncey P, Jack A, Pocock C, Ardeshna KM, Radford J, McMillan A, Davies J, Turner D, Kruger A, Johnson PW, Gambell J, Rosenwald A, Ott G, Horn H, Ziepert M, Pfreundschuh M, Linch D.

Ann Oncol. 2017 Jul 1;28(7):1540-1546. doi: 10.1093/annonc/mdx128.

PMID:
28398499
8.

Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.

Eyre TA, Osborne WL, Gallop-Evans E, Ardeshna KM, Kassam S, Sadullah S, Sidra G, Culligan D, Arumainathan A, Shankara P, Bowles KM, Eyre DW, Peng YY, Pettengell R, Bloor A, Vandenberghe E, Collins GP.

Br J Haematol. 2017 Mar 24. doi: 10.1111/bjh.14665. [Epub ahead of print] No abstract available.

PMID:
28342183
9.

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.

van Imhoff GW, McMillan A, Matasar MJ, Radford J, Ardeshna KM, Kuliczkowski K, Kim W, Hong X, Goerloev JS, Davies A, Barrigón MD, Ogura M, Leppä S, Fennessy M, Liao Q, van der Holt B, Lisby S, Hagenbeek A.

J Clin Oncol. 2016 Dec 28:JCO2016690198. [Epub ahead of print]

PMID:
28029326
10.

Author's reply.

Ardeshna KP, Rohatgi S, Jerajani HR.

Indian J Dermatol Venereol Leprol. 2017 Jan-Feb;83(1):69-70. doi: 10.4103/0378-6323.195074. No abstract available.

11.

Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection.

Maciocia N, O'Brien A, Ardeshna K.

N Engl J Med. 2016 Oct 27;375(17):1699-1701. No abstract available.

12.

Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.

Afaq A, Fraioli F, Sidhu H, Wan S, Punwani S, Chen SH, Akin O, Linch D, Ardeshna K, Lambert J, Miles K, Groves A, Kayani I.

Clin Nucl Med. 2017 Jan;42(1):e1-e7.

PMID:
27607161
13.

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial.

Gleeson M, Hawkes EA, Cunningham D, Chadwick N, Counsell N, Lawrie A, Jack A, Smith P, Mouncey P, Pocock C, Ardeshna KM, Radford J, McMillan A, Davies J, Turner D, Kruger A, Johnson PW, Gambell J, Linch D.

Br J Haematol. 2016 Nov;175(4):668-672. doi: 10.1111/bjh.14287. Epub 2016 Aug 1.

PMID:
27477167
14.

CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.

Ganeshan B, Miles KA, Babikir S, Shortman R, Afaq A, Ardeshna KM, Groves AM, Kayani I.

Eur Radiol. 2017 Mar;27(3):1012-1020. doi: 10.1007/s00330-016-4470-8. Epub 2016 Jul 5.

15.

Successful treatment of recurrent dermatophytosis with isotretinoin and itraconazole.

Ardeshna KP, Rohatgi S, Jerajani HR.

Indian J Dermatol Venereol Leprol. 2016 Sep-Oct;82(5):579-82. doi: 10.4103/0378-6323.183632. No abstract available.

16.

A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.

Kothari J, Foley M, Peggs KS, Mackenzie S, Thomson K, Morris E, Ardeshna KM, Virchis AE, Linch DC, Lambert J.

Bone Marrow Transplant. 2016 Oct;51(10):1397-1399. doi: 10.1038/bmt.2016.134. Epub 2016 May 23. No abstract available.

PMID:
27214072
17.

Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma.

Eyre TA, Linton KM, Rohman P, Kothari J, Cwynarski K, Ardeshna K, Bailey C, Osborne WL, Rowntree C, Eden D, Shankara P, Eyre DW, Jasani P, Chaidos A, Collins GP, Hatton CS.

Br J Haematol. 2016 Jun;173(6):896-904. doi: 10.1111/bjh.14021. Epub 2016 Mar 9.

PMID:
26956150
18.

A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Flinn IW, Bartlett NL, Blum KA, Ardeshna KM, LaCasce AS, Flowers CR, Shustov AR, Thress KS, Mitchell P, Zheng F, Skolnik JM, Friedberg JW.

Eur J Cancer. 2016 Feb;54:11-17. doi: 10.1016/j.ejca.2015.10.005. Epub 2015 Dec 18.

PMID:
26707592
19.

Treatment of diffuse large B-cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS-penetrating R-IDARAM chemotherapy.

Maciocia P, Badat M, Cheesman S, D'Sa S, Joshi R, Lambert J, Mohamedbhai S, Pule M, Linch D, Ardeshna K.

Br J Haematol. 2016 Feb;172(4):545-53. doi: 10.1111/bjh.13867. Epub 2015 Dec 18.

PMID:
26684148
20.

False-Positive 18F-FDG PET/CT Imaging: Dramatic "Flare Response" After Rituximab Administration.

Skoura E, Ardeshna K, Halsey R, Wan S, Kayani I.

Clin Nucl Med. 2016 Mar;41(3):e171-2. doi: 10.1097/RLU.0000000000001083.

PMID:
26647000

Supplemental Content

Loading ...
Support Center